Publications

Molecular counting enables accurate and precise quantification of methylated ctDNA for tumor-naive cancer therapy response monitoring

Nature-Scientific Reports
Feb 18, 2025

A novel liquid biopsy assay with an 88% detection rate of genomic alterations across CNS tumors.

ASCO 2024 Poster Session
May 29, 2024

Clinical validation of Northstar Select, a novel liquid biopsy assay for comprehensive genomic profiling of solid tumors.

ASCO 2024 Poster Session
May 29, 2024

Analytical and clinical validity of Northstar Select, a quantitatively enhanced liquid biopsy assay for comprehensive genomic profiling of solid tumors

AACR 2024 Poster Session
Mar 22, 2024

Methylated ctDNA dynamics correspond with clinical tumor load in metastatic lung cancer patients on therapy

AACR 2023 Poster Session
Apr 18, 2023

Novel methylation-based, tissue-free ctDNA assay accurately quantifies longitudinal tumor burden changes for precision treatment monitoring

AACR 2022 Poster Session
Apr 10, 2022
No items found.

Act with certainty. Adapt with precision.

Get in Touch